Navigating The Confluence Of AI And Community-Based Trials: Is This The Solution To Improved Diversity In Clinical Research?

Artificial intelligence (AI) is transforming clinical trials, enhancing efficiency, participation, and diversity, particularly within hybrid trial models. AI’s ability to automate participant engagement and streamline data capture has enabled clinical research to expand its global reach. This technology is playing a crucial role in improving trial accessibility for underrepresented populations, identifying patient subgroups, and tailoring trial participation.

While AI offers personalized, flexible options that can foster connection and support, there is concern that unfamiliar technology could isolate some participants. Hybrid trials, which combine traditional site visits with community-based research and mobile nurse visits, offer a solution. By leveraging AI and human touchpoints, these trials can ensure that participants remain engaged and supported. With proper implementation, AI has the potential to break down barriers, improve recruitment, and deliver faster, more efficient trials while ensuring all participants feel connected and valued.